Newsroom
Newsroom
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer....
Blog Posts
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever known. Yet despite humanity’s...
Blog Posts
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer. Pucel joins the company...
Industry News
Synthetic biology attracted $8.9 billion in venture funding during the first half of 2021, according to synbio stakeholder group SynBioBeta, and launched two successful initial...
Industry News
As a part of my series about “Lessons From Inspirational Women in STEM and Tech”, I had the pleasure of interviewing Christina Smolke......
Blog Posts
Antheia is at a critical point in scaling our production technology. Just as we bring together exceptional science and technologies to unleash the power of...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer....
Blog Posts
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever known. Yet despite humanity’s...
Blog Posts
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer. Pucel joins the company...
Industry News
Synthetic biology attracted $8.9 billion in venture funding during the first half of 2021, according to synbio stakeholder group SynBioBeta, and launched two successful initial...
Industry News
As a part of my series about “Lessons From Inspirational Women in STEM and Tech”, I had the pleasure of interviewing Christina Smolke......
Blog Posts
Antheia is at a critical point in scaling our production technology. Just as we bring together exceptional science and technologies to unleash the power of...
Industry News
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for...
Industry News
The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and...
Industry News
Until now, much of the medicines we use to treat dire illnesses have been derived from plants. But that means we are dependent on natural...
Industry News
Early this year, synthetic biologist Christina Smolke was in a dead-heat race with a handful of other labs to engineer a yeast strain capable of...
Industry News
Over the past several months, scientists from around the world have published bits and pieces of a fascinating feat: In an effort to create pain...